Expanded Access for Dasatinib
NCT00454753 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-04-29
Summary
This is an expanded access designed to provide access to dasatinib for eligible participants.
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb, Korea
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551
NCT00860353 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of AZD4205 in Healthy Adult Subjects
NCT03728023 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
NCT04105959 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lasmiditan in Healthy Chinese Participants
NCT04081324 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8848 Single Ascending Dose Study
NCT01560234 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects
NCT02257151 ·Status: COMPLETED ·Phase: PHASE1
-
Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects
NCT02364635 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants
NCT04082741 ·Status: WITHDRAWN ·Phase: PHASE1
-
Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers
NCT02446340 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels
NCT01889160 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-Escalation Study of RO7875913 in Healthy Participants
NCT07342114 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of RO5285119 in Healthy Volunteers
NCT01418963 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-Human Safety Trial of MTX-474
NCT06535841 ·Status: COMPLETED ·Phase: PHASE1
-
PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants
NCT02306915 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
NCT02790125 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy Participants
NCT06937411 ·Status: COMPLETED ·Phase: PHASE1
-
AZD5423 Multiple Ascending Dose Study
NCT01037504 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Inhaled AZD8683
NCT01419600 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8683 Single Ascending Dose Study
NCT00979849 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects
NCT00953888 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants
NCT04154800 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of BMS-823778 in Subjects With Hypercholesterolemia
NCT01112423 ·Status: COMPLETED ·Phase: PHASE2
-
GSK1349572 First Time in Human Study
NCT00555035 ·Status: COMPLETED ·Phase: PHASE1
-
AZD5672 Absolute Bioavailability Study
NCT00746837 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study
NCT00755378 ·Status: COMPLETED ·Phase: PHASE1